VM — Voyageur Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
- CA$7.64m
- CA$7.68m
R2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.076 | 0.003 | 0.813 | 0.032 | 0.002 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.098 | 0.013 | 0.042 | 0.024 | 0.036 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.398 | 0.026 | 0.887 | 0.157 | 0.089 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.2 | 1.24 | 1.67 | 1.92 | 2.06 |
Other Long Term Assets | |||||
Total Assets | 1.61 | 1.28 | 2.57 | 2.1 | 2.16 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.815 | 0.91 | 0.621 | 0.591 | 0.674 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.853 | 0.969 | 0.661 | 0.631 | 0.728 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.755 | 0.306 | 1.91 | 1.46 | 1.44 |
Total Liabilities & Shareholders' Equity | 1.61 | 1.28 | 2.57 | 2.1 | 2.16 |
Total Common Shares Outstanding |